Literature DB >> 27104844

Cushing's disease: pathobiology, diagnosis, and management.

Russell R Lonser1, Lynnette Nieman2, Edward H Oldfield3.   

Abstract

Cushing's disease (CD) is the result of excess secretion of adrenocorticotropic hormone (ACTH) by a benign monoclonal pituitary adenoma. The excessive secretion of ACTH stimulates secretion of cortisol by the adrenal glands, resulting in supraphysiological levels of circulating cortisol. The pathophysiological levels of cortisol are associated with hypertension, diabetes, obesity, and early death. Successful resection of the CD-associated ACTH-secreting pituitary adenoma is the treatment of choice and results in immediate biochemical remission with preservation of pituitary function. Accurate and early identification of CD is critical for effective surgical management and optimal prognosis. The authors review the current pathophysiological principles, diagnostic methods, and management of CD.

Entities:  

Keywords:  ATCH = adrenocorticotropic hormone; CD = Cushing's disease; CRH = corticotropin-releasing hormone; CRH-R1 = CRH receptor-1; CS = Cushing's syndrome; Cushing's disease; IPSS = inferior petrosal sinus sampling; SPGR = spoiled gradient recalled; SRS = stereotactic radiosurgery; diagnosis; oncology; surgery; treatment

Mesh:

Year:  2016        PMID: 27104844     DOI: 10.3171/2016.1.JNS152119

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  31 in total

1.  Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience.

Authors:  Philip C Johnston; Laurence Kennedy; Amir H Hamrahian; Zahrae Sandouk; James Bena; Betul Hatipoglu; Robert J Weil
Journal:  Pituitary       Date:  2017-08       Impact factor: 4.107

2.  Long Term Follow-up after Endoscopic Endonasal Approach for the Treatment of Cushing's Disease.

Authors:  Alexandre Bossi Todeschini; Américo Rubens Leite Dos Santos; Ricardo Landini Lutaif Dolci; José Viana Lima Junior; Nilza Maria Scalissi; Paulo Roberto Lazarini
Journal:  J Neurol Surg B Skull Base       Date:  2018-09-20

3.  Repeat stereotactic radiosurgery for Cushing's disease: outcomes of an international, multicenter study.

Authors:  Gautam U Mehta; Dale Ding; Amitabh Gupta; Hideyuki Kano; Nathaniel D Sisterson; Nuria Martinez-Moreno; Michal Kršek; Huai-Che Yang; Cheng-Chia Lee; Roman Liščák; Roberto Martinez-Alvarez; L Dade Lunsford; Mary Lee Vance; Jason P Sheehan
Journal:  J Neurooncol       Date:  2018-03-03       Impact factor: 4.130

4.  Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease.

Authors:  David Asuzu; Grégoire P Chatain; Christina Hayes; Sarah Benzo; Raven McGlotten; Meg Keil; Andrea Beri; Susmeeta T Sharma; Lynnette Nieman; Maya Lodish; Constantine Stratakis; Russell R Lonser; Edward H Oldfield; Prashant Chittiboina
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

5.  Celastrol Induces Apoptosis and Autophagy via the AKT/mTOR Signaling Pathway in the Pituitary ACTH-secreting Adenoma Cells.

Authors:  Zhi Cai; Bin Qian; Jing Pang; Zhou-Bin Tan; Kai Zhao; Ting Lei
Journal:  Curr Med Sci       Date:  2022-04-13

6.  Earlier post-operative hypocortisolemia may predict durable remission from Cushing's disease.

Authors:  Natasha Ironside; Gregoire Chatain; David Asuzu; Sarah Benzo; Maya Lodish; Susmeeta Sharma; Lynnette Nieman; Constantine A Stratakis; Russell R Lonser; Prashant Chittiboina
Journal:  Eur J Endocrinol       Date:  2018-01-12       Impact factor: 6.664

Review 7.  Dynamic changes of views on the brain changes of Cushing's syndrome using different computer-assisted tool.

Authors:  Lu Gao; Lu Liu; Lin Shi; Yishan Luo; Zihao Wang; Xiaopeng Guo; Bing Xing
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

8.  Prediction of recurrence and remission within 3 years in patients with Cushing disease after successful transnasal adenomectomy.

Authors:  Elena Y Nadezhdina; Olga Yu Rebrova; Andrey Y Grigoriev; Oksana V Ivaschenko; Vilen N Azizyan; Galina A Melnichenko; Ivan I Dedov
Journal:  Pituitary       Date:  2019-12       Impact factor: 4.107

9.  Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI.

Authors:  Sven Berkmann; Michel Roethlisberger; Beat Mueller; Mirjam Christ-Crain; Luigi Mariani; Egbert Nitzsche; Freimut Juengling
Journal:  Pituitary       Date:  2021-06-21       Impact factor: 4.107

10.  Management of thyrotoxicosis occurring after surgery for Cushing's disease: a case series.

Authors:  Shenzhong Jiang; Chengxian Yang; Ming Feng; Yong Yao; Kan Deng; Bing Xing; Lin Lu; Huijuan Zhu; Renzhi Wang; Xinjie Bao
Journal:  Gland Surg       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.